TGF-β-mediated EMT decreases Dlg5 expression. by Takuhito Sezaki (169150)

“…<p><b>A:</b> LLc-PK1 cells were incubated with 4 ng/ml of TGF-β for three days. …”

Characterization of the optimized nanoparticles (These values are means of a minimum of 5 batches). by Anjuman Arora (750291)

A Bcl-2-BH4 double-glycine variant (I14G/V15G) has a decreased by Giovanni Monaco (452223)

List of Included studies. by Zahra Tajik (20752452)

“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”

The search strategy in three databases. by Zahra Tajik (20752452)

“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”

NIH score. by Zahra Tajik (20752452)

“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”

List of excluded studies. by Zahra Tajik (20752452)

“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”

FGF8b decreased GnRH mRNA in GT1-7 cells. by Natasha N. Mott (341221)

TGF-β₁ increases proliferation but decreases AP activity in cultured osteoblasts. by Sabrina Ehnert (359631)

“…<p>Primary human osteoblasts were treated for 8 days with different conc. (0, 1, 2.5, 5, 10 ng/ml) of hra TGF-β₁. (A) SRB staining of surface proteins showed that TGF-β₁ dose-dependently increased proliferation of osteoblasts. …”

AQP5 expression is decreased in lung of mice exposed to hypoxia. by Jitesh D. Kawedia (384551)

Downregulation of LGR4 decreases ARPE-19 cell migration. by Qiang Hou (495704)

5-AZA decreases DNA methylation levels in neonatal hearts. by Maresha S. Gay (693467)

The G215S mutation decreases packaging of N and growth in primary differentiated human bronchial cells. by Hannah C. Kubinski (21213168)

Excision of HIF1α decreases viral reactivation from latency in infected splenocytes in vivo. by Darlah M. López-Rodríguez (8098544)

c-Yes knock-down increases apoptosis and decreases growth in soft-agar and in mouse xenografts. by Florence Sancier (229473)

Inhibition of Rab5 Activity Decreases Fluid-Phase Uptake by Carsten Schnatwinkel (48)

A flow diagram of the study entry. by Sakiko Fukui (387048)

Subjects:

IL-7 decreases apoptosis of HIV-1-infected CD4⁺ T cells. by Andrea Introini (284643)

The mutation D2267N within the G3 domain decreases the complement activation capacity. by Camilla Melin Fürst (402462)

CaMKKβ is involved in ST2-104-regulated decrease in autophagy. by Yingshi Ji (9013004)